E-LIB Suche - Ergebnisse für: Kanda, Hironori

1

Dose-Response of Tenapanor in Patients With Hyperphosphatem..:

Inaba, Masaaki ; Une, Yotaro ; Ikejiri, Kazuaki...
Kidney International Reports. 7 (2022) 2 - p. 177-188 , 2022

Link: https://doi.org/10.1016/..

2

In Reply to "Letter Regarding 'Dose-Response of Tenapanor i..:

Inaba, Masaaki ; Une, Yotaro ; Ikejiri, Kazuaki...
Kidney International Reports. 7 (2022) 7 - p. 1725-1726 , 2022

Link: https://doi.org/10.1016/..

3

Safety and Efficacy of Burosumab in Pediatric Patients With..:

Namba, Noriyuki ; Kubota, Takuo ; Muroya, Koji...
Journal of the Endocrine Society. 6 (2022) 5 - p. , 2022

Link: https://doi.org/10.1210/..

4

Effect of Tenapanor on Phosphate Binder Pill Burden in Hemo..:

Akizawa, Tadao ; Sato, Yu ; Ikejiri, Kazuaki..
Kidney International Reports. 6 (2021) 9 - p. 2371-2380 , 2021

Link: https://doi.org/10.1016/..

5

Therapeutic Effects of Add-On Tenapanor for Hemodialysis Pa..:

Shigematsu, Takashi ; Une, Yotaro ; Ikejiri, Kazuaki...
American Journal of Nephrology. 52 (2021) 6 - p. 496-506 , 2021

Link: https://doi.org/10.1159/..

6

Randomized Clinical Trial on the Effect of Bardoxolone Meth..:

Nangaku, Masaomi ; Kanda, Hironori ; Takama, Hirotaka...
Kidney International Reports. 5 (2020) 6 - p. 879-890 , 2020

Link: https://doi.org/10.1016/..

7

P1404A PHASE 2 OPEN-LABEL, SINGLE-ARM, FIRST JAPANESE STUDY..:

Fukagawa, Masafumi ; Kinoshita, Jun ; Takanuma, Masayuki..
Nephrology Dialysis Transplantation. 35 (2020) Supplement_3 - p. , 2020

Link: https://doi.org/10.1093/..

8

Bardoxolone methyl: drug development for diabetic kidney di..:

Kanda, Hironori ; Yamawaki, Kengo
Clinical and Experimental Nephrology. 24 (2020) 10 - p. 857-864 , 2020

Link: https://doi.org/10.1007/..

9

Interim Analysis of a Phase 2 Open-Label Trial Assessing Bu..:

Imanishi, Yasuo ; Ito, Nobuaki ; Rhee, Yumie...
Journal of Bone and Mineral Research. 36 (2020) 2 - p. 262-270 , 2020

Link: https://doi.org/10.1002/..

10

Randomized Comparison Study of Novel Recombinant Human Anti..:

Furuie, Hidetoshi ; Kanda, Hironori
Clinical Drug Investigation. 39 (2019) 12 - p. 1185-1194 , 2019

Link: https://doi.org/10.1007/..

11

Nrf2 activator for the treatment of kidney diseases:

Yamawaki, Kengo ; Kanda, Hironori ; Shimazaki, Ryutaro
Toxicology and Applied Pharmacology. 360 (2018) - p. 30-37 , 2018

Link: https://doi.org/10.1016/..

12

A phase 1 and dose-finding study of LY2523355 (litronesib),..:

Wakui, Hiroshi ; Yamamoto, Noboru ; Kitazono, Satoru...
Cancer Chemotherapy and Pharmacology. 74 (2014) 1 - p. 15-23 , 2014

Link: https://doi.org/10.1007/..

13

S-Mercuration of cellular proteins by methylmercury and its..:

Kanda, Hironori ; Shinkai, Yasuhiro ; Kumagai, Yoshito
The Journal of Toxicological Sciences. 39 (2014) 5 - p. 687-700 , 2014

Link: https://doi.org/10.2131/..

14

The Role of the Keap1/Nrf2 Pathway in the Cellular Response..:

Kumagai, Yoshito ; Kanda, Hironori ; Shinkai, Yasuhiro.
Oxidative Medicine and Cellular Longevity. 2013 (2013) - p. 1-8 , 2013

Link: https://doi.org/10.1155/..

15

S-Mercuration of rat sorbitol dehydrogenase by methylmercur..:

Kanda, Hironori ; Toyama, Takashi ; Shinohara-Kanda, Azusa...
Archives of Toxicology. 86 (2012) 11 - p. 1693-1702 , 2012

Link: https://doi.org/10.1007/..